Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway.
Wei X, Wang H, Liu H, Wang J, Zhou P, Li X, He Y, Li Y, Han D, Mei T, Wang Y, Li Z, Ning J, Xu Z, Wang A, Li Y, Cheng J, Qian D.
Wei X, et al. Among authors: zhou p.
J Immunother Cancer. 2025 Jan 7;13(1):e009993. doi: 10.1136/jitc-2024-009993.
J Immunother Cancer. 2025.
PMID: 39773565